25th January 2021  Product update: rapidmicrobiology staff writer

Bioperfectus' Rapid Test is Vital for Post-Vaccination Era


As the world continues the COVID-19 battle, we still have a large number of testing requirements in the post-vaccination era and the rapid test is the first choice due to its unique features.

Antigen testing with a 15-minute turnaround time-to-result makes detection more efficient and can be done without the need for specific instruments or laboratory devices.

The Bioperfectus Technologies Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.

Advantages:​

  • Fast: results within 15 minutes
  • Easy to use: 3 steps to finish the test
  • Complete: all necessary components provided
  • Safe: swab in protective packaging to avoid biohazard
  • Quality Control: ensures the result is reliable

Parameters:

  • Clinical Sensitivity: 96.7%
  • Clinical Specificity: 97.9%
  • Limit of Detection: 1.0 x 102 TCID50/mL
  • Sample type: nasal/nasopharyngeal swabs
  • Storage temperature: 4 - 30oC
  • Transportation temperature: -20 - 45oC

 

Catalog Number: SC30107W
Product Name: Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit
Package: 20 or 50 Tests per box
Certificate: CE-IVD marking.

To learn more, please click here,​ or use the Request information button provided below.


    

Tags:

Date Published: 25th January 2021

Source article link: View

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.


View full company details




Jiangsu Bioperfectus Technologies Co., Ltd.

Address:

China Medical City

China

Tel: +86 021-64193032

Email Supplier

View full company details


Related news from Jiangsu Bioperfectus Technologies Co., Ltd.